Congress trades

Exelixis, Inc. (EXEL)

NASDAQ · Healthcare · 6 congress trades · last filed 3 years ago

6
Congress disclosures shown
29d
Median delay on the congress disclosures
of the 45 day limit
3 buys·3 sells
Purchases and sales in the disclosures shown
Get a push when a member of Congress trades EXEL.

Free on iOS and Android.

About Exelixis, Inc.

from the company's filings and listing, as of Oct 25, 2026
Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology
Chief executive
Michael Morrissey
Employees
1,077
Listed since
Apr 17, 2000
Market value
$16.2B
Price to earnings (12 mo)
19.6
Net income per share, as reported (12 mo)
$3.43
Dividend yield
-

www.exelixis.com

Earnings

6 reported quarters · next on Oct 29, 2026
QuarterEPSEPS expectedRevenueRevenue expectedResult
Q2 FY2026reported Aug 5, 2026$0.91$0.85$628.7M$636.4MEPS beatRevenue in line
Q1 FY2026reported May 5, 2026$0.87$0.77$610.8M$607.5MEPS beatRevenue in line
Q4 FY2025reported Feb 10, 2026$0.94$0.77$598.7M$596.5MEPS beatRevenue in line
Q3 FY2025reported Nov 4, 2025$0.78$0.69$597.8M$590.2MEPS beatRevenue in line
Q2 FY2025reported Jul 28, 2025$0.75$0.65$568.3M$594.9MEPS beatRevenue miss
Q1 FY2025reported May 13, 2025$0.62$0.36$555.4M$499.6MEPS beatRevenue beat

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.

Executive pay

as filed for fiscal 2025 · proxy filed Apr 15, 2026
ExecutiveSalaryStock awardsOtherTotal
Michael M. Morrissey, Ph.D.President and Chief Executive Officer$1.3M$30.5M$1.4M$33.2M
Christopher J. SennerExecutive Vice President and Chief Financial Officer$823K$9.3M$482K$10.6M
Dana T. Aftab, Ph.D.Executive Vice President, Research and Development$659K$9.5M$408K$10.5M
Patrick J. HaleyExecutive Vice President, Commercial$621K$8.1M$338K$9.0M
Brenda J. HeftiJ.D., Ph.D. Senior Vice President and General Counsel$455K$3.5M$298K$4.2M

The summary compensation table from the proxy statement for fiscal 2025, with titles as filed then. 2 executives who have since left the company are named in that filing and not shown here. Read the filing

Institutional holders

13F positions as of Jun 30, 2026
HolderValueSharesShares vs prior qtr% of shares out
BlackRock, Inc.$1.6B29,075,377-5.6%11.59%
Farallon Capital Management, L.L.C.$732.8M13,468,010+2.7%5.37%
Renaissance Technologies LLC$730.6M13,427,993-2.2%5.35%
Vanguard Portfolio Management LLC$655.3M12,043,122-0.3%4.80%
AQR Capital Management LLCCliff Asness$598.6M11,023,943-15.8%4.40%
Vanguard Capital Management LLC$595.8M10,950,997-2.7%4.37%
State Street Corp$542.5M9,970,071-3.2%3.98%
Fuller & Thaler Asset Management, Inc.$485.8M8,929,389+4.5%3.56%
LSV Asset Management$443.3M8,146,478+5.2%3.25%
Geode Capital Management, LLC$416.3M7,650,316-1.9%3.05%
D. E. Shaw & Co., Inc.$302.1M5,551,747+54.1%2.21%
Morgan Stanley$245.9M4,519,684+8.2%1.80%

A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.

Tracked fund managers holding EXEL

2 managers
ManagerValueSharesShare of book
Farallon Capital$732.8M13,468,0103.4%
Renaissance TechnologiesJim Simons$730.6M13,427,9931.0%

2 of the 97 fund managers we track list EXEL shares among the largest positions in their latest 13F, filed for Q2 2026. A manager can hold it further down the book too, so this is a floor, not a count. Share of book is the position against the manager's whole disclosed 13F value.

Know when the next EXEL filing is reported.

GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.

Congress trades in EXEL

6 disclosures of 6 on record · median 29d of the 45 allowed

Since the trade: the stock's move from the trade date to the latest close we hold (figures as of Oct 24, 2026), not the member's result. Not investment advice.

MemberTypeActionAmount disclosedStock since the tradeTrade dateDisclosedDelay
Ro KhannaStockSale$1,001 - $15,000+182.3%After the saleS&P 500 +59.5% · +122.8 pts vs S&P 500Jan 10, 2024Feb 5, 202426d
Ro KhannaStockPurchase$1,001 - $15,000+287.1%S&P 500 +93.0% · +194.1 pts vs S&P 500Dec 6, 2022Jan 6, 202331d
Ro KhannaStockSale$1,001 - $15,000+240.5%After the saleS&P 500 +134.4% · +106.2 pts vs S&P 500Jan 8, 2020Feb 10, 202033d
Ro KhannaStockPurchase$1,001 - $15,000+340.8%S&P 500 +181.5% · +159.3 pts vs S&P 500Oct 25, 2018Nov 9, 201815d
Ro KhannaStockSale$1,001 - $15,000+228.6%After the saleS&P 500 +173.1% · +55.5 pts vs S&P 500Jun 15, 2018Jul 11, 201826d
Ro KhannaStockPurchase$1,001 - $15,000+203.2%S&P 500 +191.7% · +11.5 pts vs S&P 500Apr 3, 2018May 10, 201837d

Since the trade is an estimate, set beside the S&P 500 over the same window, with the gap between the two in percentage points. The filing carries a band, not a fill, and a sale keeps the stock's sign, so a positive figure after a sale means the stock kept rising after it. An option row carries the underlying stock's move. A row marked n/a is one we hold no figure for.

Every Congress trade in EXEL, filterable by party, chamber, type and account.

Questions

Which members of Congress have traded EXEL?

Ro Khanna disclosed EXEL transactions in the filings shown here.

How quickly are EXEL trades disclosed?

Congressional disclosures took a median of 29 days, against the 45 the STOCK Act allows.

How to read a STOCK Act filing

WHAT THE FILING ACTUALLY SAYS

$A range, not an amount. Members disclose a band such as $1,001 to $15,000. The band is the filing, and we do not narrow it.
45Up to 45 days after the trade, lawfully. The delay column counts calendar days from the transaction to its publication. Inside 45 days is within the law.
OPAn option names the underlying. A contract on a company is described using that company's name, so it can read like a share purchase. Those rows say otherwise.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

Data as of Oct 26, 2026.

Related companies

traded by the same members

See every company we track